| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/01616412.2015.1133025 |
| P698 | PubMed publication ID | 26905383 |
| P2093 | author name string | Tarik F Massoud | |
| Ramasamy Paulmurugan | |||
| Jeyarama S Ananta | |||
| P2860 | cites work | Malignant gliomas in adults | Q29615708 |
| Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas | Q30885145 | ||
| Brain cancer diagnosis and therapy with nanoplatforms | Q31077438 | ||
| Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. | Q33879575 | ||
| Blood-brain barrier drug targeting: the future of brain drug development | Q33976325 | ||
| Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials | Q34429383 | ||
| Drug and gene targeting to the brain with molecular Trojan horses | Q34742814 | ||
| The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier | Q35585191 | ||
| The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior | Q35719594 | ||
| Impact of temozolomide on immune response during malignant glioma chemotherapy | Q36362798 | ||
| Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review | Q36456955 | ||
| Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma | Q39367525 | ||
| Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model. | Q39457556 | ||
| MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature | Q39646080 | ||
| Gene expression profiling predicts response to temozolomide in malignant gliomas | Q39709566 | ||
| Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice | Q39780213 | ||
| A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles | Q39930317 | ||
| Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro | Q40227874 | ||
| Paclitaxel nanoparticles for the potential treatment of brain tumors | Q40513384 | ||
| Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release | Q40934871 | ||
| Pharmacological blood-brain barrier modification for selective drug delivery | Q41096793 | ||
| Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates | Q44390085 | ||
| Brain uptake of thiamine-coated nanoparticles | Q44673525 | ||
| Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration | Q45864572 | ||
| Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure | Q45875570 | ||
| Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). | Q46355807 | ||
| Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties | Q48087236 | ||
| Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues | Q48520331 | ||
| Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery | Q48669431 | ||
| BBB-Genomics: creating new openings for brain-drug targeting | Q48919251 | ||
| P433 | issue | 1 | |
| P921 | main subject | temozolomide | Q425088 |
| nanoparticle | Q61231 | ||
| glioblastoma | Q282142 | ||
| P304 | page(s) | 51-59 | |
| P577 | publication date | 2016-02-23 | |
| P1433 | published in | Neurological Research | Q15765622 |
| P1476 | title | Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation | |
| P478 | volume | 38 |
| Q90216674 | Core‑shell type thermo‑nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells |
| Q42320927 | Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles |
| Q92571148 | Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine |
| Q41141280 | Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433). |
| Q59137460 | PLGA-Based Nanoparticles in Cancer Treatment |
| Q48175785 | Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies |
| Q55257510 | Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model. |
| Q89967466 | The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications |
Search more.